According to a recent study, patients with hidradenitis suppurativa (HS) are at an increased risk of anxiety disorders such as phobic disorders, panic disorder, generalized anxiety disorder or unspecified anxiety.
Isotretinoin efficacious in treating transgender patients receiving gender-affirming treatment
According to a recent study, isotretinoin is effective and well tolerated in transgender individuals with acne receiving masculinizing gender-affirming hormonal therapy.
Older patients on antihypertensive medications at increased risk of eczematous dermatitis
According to a recent study, older adults taking antihypertensive drugs are at an increased risk of eczematous dermatitis.
Crisaborole efficacious long-term in treating mild-to-moderate AD
According to a recent study, daily crisaborole ointment was efficiacious in treating mild-to-moderate atopic dermatitits (AD) long-term.
Tildrakizumab efficacious in treating scalp psoriasis
According to a recent study, tildrakizumab was shown to be efficacious in treating moderate-to-severe plaque psoriasis on the scalp.
Topical treatment improves sleep quality in PsO, AD patients
According to a recent study, topical treatment decreases itch and improves sleep patterns in patients with psoriasis and atopic dermatitis.
Study finds link between skin disorder visibility and stigma
According to a recent study, the visibility of a skin disorder is directly linked to stigma including bullying.
Antibiotics in first year of life linked to increased AD risk in infants
According to a recent study, early-life antibiotic use affects the gut microbiome which may lead to an increased risk of atopic dermatitis (AD).
Patients with HS at higher risk of respiratory disease
According to a recent study, hidradenitis suppurativa (HS) patients are at higher risk for respiratory diseases.
Depression, suicidal ideation low in PsO patients on bimekizumab, according to new study
According to a recent study, suicidal ideation and behaviour and depression are low and within general psoriasis ranges in patients being treated with bimekizumab.
HealthMinute.TV 